Neglected Tropical Diseases: Challenges, Strategies, and Global Progress

This article is presented by GBL4, a dedicated team championing the implementation of game-based learning for effective behavior change. With a strong emphasis on One Health, we believe in the power of interactive approaches to educate both the public and professional communities. Our aim is to ensure that vital concepts are not just understood but are applied in everyday practice. As professionals in the One Health domain or those with a keen interest in related topics, you'll find value in our discussions on topics ranging from zoonotic diseases to the UN sustainability goals. Dive in to explore the intricate connections between One Health, public health, biodiversity, and more. Visit us at GBL4.org to learn more and see what we are working on.

Understanding Neglected Tropical Diseases (NTDs)

Neglected Tropical Diseases (NTDs) refer to a diverse group of infections that primarily affect impoverished communities in tropical and subtropical regions. These diseases, caused by bacteria, viruses, parasites, and fungi, impose a significant health and socioeconomic burden on over one billion people globally. They lead to severe disabilities, disfigurement, and chronic suffering, further trapping communities in cycles of poverty.

The World Health Organization (WHO) recognizes 20 NTDs, including lymphatic filariasis, schistosomiasis, trachoma, Chagas disease, leishmaniasis, and onchocerciasis (river blindness). These diseases share common characteristics: they thrive in areas with inadequate sanitation, limited healthcare access, and weak disease surveillance. Despite their devastating impact, NTDs historically received limited funding and attention compared to major infectious diseases like malaria, HIV/AIDS, and tuberculosis.

Criteria for Neglected Tropical Diseases

NTDs are classified based on several criteria:

1. High Prevalence in Impoverished Regions – NTDs disproportionately affect communities with inadequate access to clean water, sanitation, and healthcare.
2. Chronic and Disabling Effects – Many NTDs cause long-term disabilities, disfigurement, and social stigma.
3. Limited Market Incentives for Treatment Development – Pharmaceutical companies have shown less interest in developing treatments for NTDs due to a perceived lack of profitability.
4. Potential for Elimination or Control – Many NTDs can be controlled or eliminated through mass drug administration, improved sanitation, and vector control.

These criteria highlight why a global, coordinated effort is necessary to tackle these diseases effectively.

Current Strategies to Combat NTDs

The global fight against NTDs has gained momentum, with organizations such as WHO, the CDC, and nonprofit initiatives leading integrated approaches to control and eliminate these diseases. Some of the key strategies include:

1. Mass Drug Administration (MDA)

One of the most cost-effective methods for combating NTDs is MDA, where entire populations in endemic regions receive preventive treatment. This approach has led to remarkable progress, including:

• 760 million people no longer requiring treatment for lymphatic filariasis.
• A drastic reduction in human cases of Guinea worm disease, from 3.5 million in the 1980s to just 13 cases in 2023.

2. Improved Sanitation and Hygiene (WASH Programs)

Many NTDs are linked to poor sanitation and unsafe water. Integrated programs that provide clean drinking water, promote hygiene practices, and improve waste management have proven effective in reducing disease transmission.

3. Vector Control Measures

Diseases like dengue, Chagas disease, and leishmaniasis are transmitted by insects. Controlling vector populations through insecticide-treated nets, environmental management, and biological control methods has been a crucial component in reducing disease incidence.

4. Strengthening Healthcare Systems and Surveillance

Early diagnosis and timely treatment are critical for managing NTDs. WHO’s 2021–2030 road map emphasizes the need for stronger health systems, improved diagnostic tools, and better disease surveillance to track progress toward elimination goals.

5. Research and Development for New Treatments

Despite progress, significant gaps remain in drug development. Historically, only a small fraction of pharmaceutical research funding has been allocated to NTDs, despite their massive disease burden. Organizations like the Drugs for Neglected Diseases initiative (DNDi) are working to develop new treatments and repurpose existing drugs.

Success Stories in NTD Control and Elimination

1. Elimination of Dracunculiasis (Guinea Worm Disease)

Through coordinated efforts led by WHO and The Carter Center, Guinea worm disease is on the verge of eradication. The number of reported cases has dropped from millions in the 1980s to just 13 in 2023, largely due to simple interventions like safe water filtration and community-based surveillance.

2. Trachoma Elimination in Ghana

Ghana became the first country in sub-Saharan Africa to eliminate trachoma as a public health problem. This achievement was made possible through a combination of MDA, improved sanitation, and surgical interventions for advanced cases.

3. River Blindness (Onchocerciasis) Control in Africa

Mass treatment programs using ivermectin have drastically reduced the prevalence of onchocerciasis in several African countries. In some regions, transmission has been interrupted, paving the way for elimination.

4. Leprosy Elimination in Several Countries

WHO’s multidrug therapy (MDT) campaign has significantly reduced the burden of leprosy. More than 16 million patients have been treated since the 1980s, leading to the elimination of leprosy as a public health concern in many countries.

Challenges and the Road Ahead

While significant progress has been made, several challenges remain:

• Funding and Resource Gaps – Many NTD programs rely on donated drugs and international funding, making sustainability uncertain.
• Political Instability in Endemic Regions – Conflict zones and fragile health systems hinder disease elimination efforts.
• Climate Change and Emerging Threats – Rising temperatures and environmental changes may expand the range of NTDs, increasing transmission in new areas.
• Need for New Diagnostics and Vaccines – Many NTDs still lack effective vaccines or rapid diagnostic tools.

To meet the WHO’s 2030 targets, continued investment in research, innovative treatment approaches, and global partnerships is critical.

Conclusion

Neglected tropical diseases remain a significant global health challenge, disproportionately affecting the most vulnerable populations. However, with continued investment, community engagement, and cross-sector collaboration, the elimination of many NTDs is within reach.

Thank you for taking the time to engage with this article. GBL4 is committed to shedding light on critical topics around zoonosis, patient care, and the broader implications of One Health. We invite you to delve deeper into these subjects by visiting GBL4.org. Stay updated with our latest insights by subscribing to our newsletter and following us on LinkedIn. Your thoughts and feedback are invaluable to us, so please feel free to comment on the article and join the conversation. Together, we can drive meaningful change and foster a better understanding of the interconnectedness of our world.

References

World Health Organization. (2020). Neglected tropical diseases. Retrieved from https://apps.who.int/gb/ebwha/pdf_files/WHA73/A73_8-en.pdf

Centers for Disease Control and Prevention. (2024). Neglected tropical diseases fact sheet. Retrieved from https://www.cdc.gov/parasites/resources/pdf/NTD_FactSheet_2024.pdf

Drugs for Neglected Diseases initiative. (2014). Balancing fatal imbalance: Neglected tropical diseases and their control in developing countries. Retrieved from https://dndi.org/wp-content/uploads/2014/01/Wasunna_KASH_NTDs%20Balancing-Fatal-Imbalance_2014.pdf

Sightsavers. (2020). Neglected tropical diseases brief. Retrieved from https://www.sightsavers.org/wp-content/uploads/2020/11/Overarching-NTDs-Brief.pdf

Blum, J., Hatz, C., & Hatz, C. (2018). Neglected tropical diseases: Diagnosis, clinical management, treatment, and control. Swiss Medical Weekly, 148, w20184. Retrieved from https://smw.ch/index.php/smw/article/download/1615/2112/5643